Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3099358

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
C/C1=C\[C@@H]2O[C@@H](O)[C@@]3(C)O[C@@]23CC/C(C)=C/CC[C@](C)(O)[C@@H](O)CC1

Basic Information

ChEMBL ID CHEMBL3099358
Phase Preclinical
Structure Type MOL
InChI Key FCPVMRGLYDLISU-NJRUTKOHSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names

Molecular Properties

352.5
MW (Da)
2.59
ALogP
5
HBA
3
HBD
82.5
PSA (Ų)
0.46
QED
0
Ro5 Violations
0
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

Natural Product First in Class Prodrug

Extended Properties

Molecular Formula C20H32O5
MW 352.47
Aromatic Rings 0
Heavy Atoms 25
NP-Likeness 3.15

Activity Summary

IC50 1 meas. best 5.2

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.2 5.2 6300.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 6300.0 nM 5.2 Inhibition of TNF-alpha-induced NF-kappaB transcriptional activation in human He... 24314396

Literature References

PubMed DOI Target Context # Activities
24314396 10.1016/j.bmcl.2013.11.033 Unchecked 2
24314396 10.1016/j.bmcl.2013.11.033 HepG2 2

Data from ChEMBL 36 via Core Engine